Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval

• Emily A. King ,

  Roles Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: emily.king@abbvie.com

  Affiliation Department of Computational Genomics, AbbVie, North Chicago, Illinois, United States of America

  http://orcid.org/0000-0003-1877-8673

  ⨯
• J. Wade Davis,

  Roles Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Visualization, Writing – review & editing

  Affiliation Department of Computational Genomics, AbbVie, North Chicago, Illinois, United States of America

  ⨯
• Jacob F. Degner

  Roles Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Visualization, Writing – review & editing

  Affiliation Department of Computational Genomics, AbbVie, North Chicago, Illinois, United States of America

  ⨯